We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$319M
AUM Growth
+$61.2M
Cap. Flow
+$48.2M
Cap. Flow %
15.12%
Top 10 Hldgs %
53.4%
Holding
46
New
14
Increased
9
Reduced
16
Closed
7

Top Buys

1
MRK icon
Merck
MRK
+$18.4M
2
CELG
Celgene Corp
CELG
+$18.2M
3
AXTA icon
Axalta
AXTA
+$10.8M
4
CNH
CNH Industrial
CNH
+$9.69M
5
BMY icon
Bristol-Myers Squibb
BMY
+$9.03M

Top Sells

1
SHPG
Shire pic
SHPG
+$15.5M
2
PPG icon
PPG Industries
PPG
+$12.3M
3
ECL icon
Ecolab
ECL
+$9.14M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$5.22M
5
TIMB icon
TIM SA
TIMB
+$4.3M

Sector Composition

1 Healthcare 39.1%
2 Materials 14.63%
3 Communication Services 11.68%
4 Financials 7.58%
5 Industrials 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNH
1
CNH Industrial
CNH
$13.2B
$22.4M 7.03%
3,598,810
+1,559,831
+77% +$9.69M
GILD icon
2
Gilead Sciences
GILD
$167B
$20.4M 6.39%
257,759
+66,804
+35% +$5.43M
MRK icon
3
Merck
MRK
$315B
$18.8M 5.88%
+315,142
New +$18.4M
CELG
4
DELISTED
Celgene Corp
CELG
$17.6M 5.51%
+167,998
New +$18.2M
QGENF
5
DELISTED
QIAGEN NV
QGENF
$17.4M 5.45%
630,990
-11,762
-2% -$324K
TIMB icon
6
TIM SA
TIMB
$10.6B
$17.1M 5.35%
1,393,523
-348,579
-20% -$4.3M
ASH icon
7
Ashland
ASH
$3.14B
$16.2M 5.07%
285,089
+125,935
+79% +$7.23M
AGN
8
DELISTED
Allergan plc
AGN
$16.1M 5.05%
69,993
-15,822
-18% -$3.87M
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$12.4M 3.88%
100,933
-40,521
-29% -$5.22M
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$11.5B
$12.1M 3.79%
130,538
-32,684
-20% -$3.08M
SHPG
11
DELISTED
Shire pic
SHPG
$11M 3.44%
56,535
-79,679
-58% -$15.5M
AXTA icon
12
Axalta
AXTA
$6.92B
$10.9M 3.43%
+386,448
New +$10.8M
APD icon
13
Air Products & Chemicals
APD
$65.8B
$10.9M 3.42%
78,403
-14,992
-16% -$2.08M
CRTO icon
14
Criteo
CRTO
$1.13B
$10.6M 3.31%
300,549
+164,741
+121% +$6.52M
C icon
15
Citigroup
C
$217B
$9.72M 3.05%
205,876
-41,805
-17% -$1.9M
VVV icon
16
Valvoline
VVV
$5.1B
$8.88M 2.79%
+378,155
New +$8.92M
LYB icon
17
LyondellBasell Industries
LYB
$19.1B
$8.65M 2.71%
+107,207
New +$8.29M
GCP
18
DELISTED
GCP Applied Technologies Inc.
GCP
$8.34M 2.62%
294,540
+58,554
+25% +$1.63M
UBS icon
19
UBS Group
UBS
$173B
$8.07M 2.53%
592,656
-35,661
-6% -$485K
GRA
20
DELISTED
W.R. Grace & Co.
GRA
$7.97M 2.5%
108,049
+29,092
+37% +$2.19M
BMY icon
21
Bristol-Myers Squibb
BMY
$124B
$7.58M 2.38%
+140,525
New +$9.03M
BAC icon
22
Bank of America
BAC
$430B
$6.37M 2%
406,784
-250,060
-38% -$3.72M
TMUS icon
23
T-Mobile US
TMUS
$208B
$6.16M 1.93%
131,865
-24,135
-15% -$1.11M
APTV icon
24
Aptiv
APTV
$12.2B
$4.93M 1.55%
69,177
-21,480
-24% -$1.45M
DBVT
25
DBV Technologies
DBVT
$870M
$4.59M 1.44%
12,631
-878
-6% -$305K
1
2

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, Exane Asset Management held 46 positions worth $319M, up 24% from $258M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Exane Asset Management deployed $48.2M of net new capital in Q3 2016, opening 14 new positions and adding to 9 existing holdings. Its largest new stake was Merck: 315,142 shares worth $18.8M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Shire pic, an estimated $15.5M trimmed.

  • Exane Asset Management's largest Q3 2016 buy was Merck: 315,142 shares worth $18.8M.
  • Exane Asset Management added most to CNH Industrial in Q3 2016, an estimated $9.69M increase.
  • Exane Asset Management's biggest Q3 2016 reduction was Shire pic, cutting an estimated $15.5M.
  • Exane Asset Management fully exited PPG Industries in Q3 2016, selling an estimated $12.3M.
  • Exane Asset Management's ten largest holdings make up 53% of its $319M portfolio in Q3 2016.
  • Exane Asset Management opened 14 new positions and closed 7 in Q3 2016.
  • Exane Asset Management's portfolio value rose 24% quarter-over-quarter to $319M.

Based on Exane Asset Management's 13F filing for Q3 2016, filed 26 Oct 2016.